Drug intelligence / Profile preview

polynucleotide + hyaluronic acid

Development stage
Preclinical
Lead developer
Reanzen
Administration
Intradermal
01

Overview

PN + HA is a combination biomaterial and skin booster developed by Reanzen, designed for aesthetic and regenerative applications such as treating skin aging, wrinkles, and dermal tissue damage. The product integrates polynucleotides (PN)—DNA fragments typically derived from salmon—with hyaluronic acid (HA). The polynucleotide component functions by stimulating adenosine A2A receptors and providing nucleotides for the DNA salvage pathway, which promotes fibroblast proliferation, collagen synthesis, and tissue repair. The hyaluronic acid component provides immediate volumization and deep hydration by binding water molecules and interacting with CD44 receptors on skin cells. Reanzen employs its proprietary Hyaluronic acid Moisture Technology (HMT) and Optimal Cross-linking Technology (OCT) to enhance the stability and efficacy of the combination, aiming to restore skin elasticity and repair damaged dermal structures.

Other names
PN/HAPolynucleotide + Hyaluronic Acid
02

Targets

ADORA2A (Adenosine A₂A Receptor)CD44 (CD44 antigen)

Beyond the preview

Go deeper on polynucleotide + hyaluronic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polynucleotide + hyaluronic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call